文献速递慢性肾脏病急性肾损伤血液净化与透析

纵向B型利钠肽监测与慢性肾脏病患者肾衰竭风险的关联:一项队列研究

Association of Longitudinal B-Type Natriuretic Peptide Monitoring With Kidney Failure in Patients With CKD: A Cohort Study.
PubMed 文献 · Am J Kidney Dis · 2023-06-23

该回顾性队列研究纳入2998例未透析的3-5期慢性肾脏病门诊患者,评估纵向B型利钠肽(BNP)监测与肾脏替代治疗(KRT)风险的关系。中位随访5.9年期间,BNP监测与较低的KRT风险(HR 0.44)、急性肾损伤(AKI)风险(HR 0.36)和心力衰竭住院风险(HR 0.37)相关,且KRT关联在额外调整AKI或心衰住院后减弱。

要点

  • 在未透析的3-5期慢性肾脏病患者中,BNP监测与较低的KRT风险相关(HR 0.44)。
  • BNP监测同时与较低的AKI风险(HR 0.36)和心衰住院风险(HR 0.37)相关。
  • KRT关联在额外调整AKI或心衰住院后减弱,提示可能通过减少AKI或心衰住院介导。

核心结论

  • 在未透析的慢性肾脏病患者中,BNP监测与较低的KRT风险相关,该关联可能通过降低AKI或心衰住院风险介导。

研究设计与样本

  • 回顾性队列研究,纳入2998例转诊至某学术医院肾内科的未透析3-5期慢性肾脏病门诊患者。
  • 暴露为BNP监测,结局为KRT、AKI和心衰住院,采用边际结构模型和逆概率加权合并逻辑回归估计风险比。

主要发现

  • 基线中位年龄66岁,中位估算肾小球滤过率为38.1mL/min/1.73m2。
  • 中位随访5.9年(IQR 2.8-9.9)期间,449例需要KRT,765例发生AKI,236例因心衰住院。
  • 调整时间更新临床特征和医生实践风格后,BNP监测与较低的KRT风险(HR 0.44,95%CI 0.21-0.92)、AKI风险(HR 0.36,95%CI 0.18-0.72)和心衰住院风险(HR 0.37,95%CI 0.14-0.95)相关。
  • 额外将AKI或心衰住院作为时变协变量调整后,BNP监测与KRT的关联减弱。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 残余混杂,包括已测量和未测量变量或BNP测量指征。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE & OBJECTIVE: Both hypervolemia and hypovolemia are associated with chronic kidney disease (CKD) progression. Although longitudinal monitoring of B-type natriuretic peptide (BNP) may aid physicians' decision making about the optimization of volume status, its clinical benefit remains uncertain in CKD. This study assessed the association between BNP monitoring and the risk of incident kidney replacement therapy (KRT). STUDY DESIGN: Retrospective cohort study. SETTING & PARTICIPANTS: A total of 2,998 outpatients with stages 3-5 of nondialyzed CKD referred to the department of nephrology at an academic hospital. EXPOSURE: BNP monitoring. OUTCOME: KRT, acute kidney injury (AKI), and heart failure hospitalization. ANALYTICAL APPROACH: Marginal structural models, which create a balanced pseudo population at each time point, were applied to account for potential time-dependent confounders. Inverse probability weighted pooled logistic regression models were employed to estimate hazard ratios. RESULTS: At baseline, the median age and estimated glomerular filtration rate were 66 years and 38.1mL/min/1.73m2, respectively. During the follow-up period (median, 5.9 [IQR, 2.8-9.9] years), 449 patients required KRT, 765 had AKI, and 236 were hospitalized for heart failure. After adjustment for time-updated clinical characteristics and physician-specific practice styles, BNP monitoring was associated with lower risks of KRT (HR, 0.44 [95% CI, 0.21-0.92]), AKI (HR, 0.36 [95% CI, 0.18-0.72]), and heart failure hospitalization (HR, 0.37 [95% CI, 0.14-0.95]). The association between BNP monitoring and KRT was attenuated after additional adjustment for AKI or heart failure hospitalization as a time-varying covariate. LIMITATIONS: Residual confounding by measured and unmeasured variables or indications for BNP measurements. CONCLUSIONS: BNP monitoring was associated with a lower risk of KRT among patients with CKD that did not require dialysis. This association is potentially mediated through a reduced risk of AKI or heart failure hospitalization. PLAIN-LANGUAGE SUMMARY: Both volume overload and volume depletion are deleterious to kidney function. B-type natriuretic peptide (BNP) is a biomarker that reflects volume status not only in heart failure but also in nondialysis chronic kidney disease (CKD). Although longitudinal BNP monitoring may aid physicians' decision making about the optimization of volume status, its clinical benefit remains uncertain in CKD. In this cohort study analyzing 2,998 patients with nondialyzed CKD, BNP monitoring was associated with a lower risk of kidney replacement therapy, acute kidney injury, and heart failure hospitalization over the follow-up period. The association with kidney replacement therapy may be mediated through a reduced risk of acute kidney injury or heart failure hospitalization. BNP monitoring may aid physicians in optimal fluid management, potentially conferring better kidney outcomes.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Oka T, Sakaguchi Y, Hattori K, et al. Association of Longitudinal B-Type Natriuretic Peptide Monitoring With Kidney Failure in Patients With CKD: A Cohort Study. Am J Kidney Dis. 2023. PMID: 37354935. doi:10.1053/j.ajkd.2023.05.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。